Search Results - Kadamyan-Melkumian, Vera

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure

    A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure by Massarweh, Suleiman, Romond, Edward, Black, Esther P., Van Meter, Emily, Shelton, Brent, Kadamyan-Melkumian, Vera, Stevens, Mark, Elledge, Richard

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Erratum to: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure

    Erratum to: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure by Massarweh, Suleiman, Romond, Edward, Black, Esther P., Van Meter, Emily, Shelton, Brent, Kadamyan-Melkumian, Vera, Stevens, Mark, Elledge, Richard

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor failure

    A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor failure by Massarweh, Suleiman, Romond, Edward, Black, Esther P, Van Meter, Emily, Shelton, Brent, Kadamyan-Melkumian, Vera, Stevens, Mark, Elledge, Richard

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: